NASDAQ

First Tracks Biotherapeutics, Inc. - Ordinary Shares (TRAX)

♥ 608 Thanks from members

Live price chart, market sentiment, and community perspectives for First Tracks Biotherapeutics, Inc. (NASDAQ: TRAX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: First Tracks Biotherapeutics TeamLeadership: Executive Management TeamHolder: Venture Capital InvestorsHolder: InsidersBiotherapeutic PipelineImmunology Treatments#TRAX#First Tracks Biotherapeutics#Biotech IPO#NASDAQ TRAX#Rare Disease Therapeutics